LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Rokos Capital Management LLP's Holding History (CIK: 0001666335)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 5,000 Value ($000) $81 Avg Close — Range —